عنوان
پدید آورنده
موضوع
رده
RC848.H42 .P69 2004eb
RC848
.
H42
.
P69
2004eb
کتابخانه
محل استقرار
INTERNATIONAL STANDARD BOOK NUMBER
(Number (ISBN
0203357183
(Number (ISBN
9780203357187
Erroneous ISBN
1841843695
Erroneous ISBN
9781841843698
NATIONAL BIBLIOGRAPHY NUMBER
Number
b786155
TITLE AND STATEMENT OF RESPONSIBILITY
Title Proper
Hepatitis C and B :
General Material Designation
[Book]
Other Title Information
management and treatment /
First Statement of Responsibility
Thierry Poynard.
EDITION STATEMENT
Edition Statement
2nd ed.
.PUBLICATION, DISTRIBUTION, ETC
Place of Publication, Distribution, etc.
London :
Name of Publisher, Distributor, etc.
Taylor & Francis,
Date of Publication, Distribution, etc.
2004
Date of Manufacture
(2005 printing)
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
1 online resource (v, 168 pages) :
Other Physical Details
color illustrations, color maps
GENERAL NOTES
Text of Note
"A Martin Dunitz book."
Text of Note
Previous ed. published as: Hepatitis C infection. London : Martin Dunitz, 2000.
INTERNAL BIBLIOGRAPHIES/INDEXES NOTE
Text of Note
Includes bibliographical references and index.
CONTENTS NOTE
Text of Note
""Book Cover""; ""Title""; ""Copyright""; ""Contents""; ""Introduction""; ""I Hepatitis C""; ""1. Natural History of Hepatitis C: Epidemiology""; ""2. Natural History of Hepatitis C: Hepatic Manifestations""; ""3. Natural of Hepatitis C: Extrahepatic Manifestations and Quality of Life""; ""4. Management Protocols in Chronic Hepatitis C""; ""5. Management of Relapsers and Nonresponders�Maintenance Therapy""; ""6. Management of Patients with Cirrhosis""; ""7. Management of Patients Coinfected by HCV and HIV""; ""8. Management of HCV Infection After Liver Transplantation""
Text of Note
""18. Natural History of Hepatitis B: Hepatic Manifestations""""19. Natural History of Hepatitis B: Extrahepatic Manifestations and Quality of Life""; ""20. Goal of Treatment in Chronic Hepatitis B""; ""21. Efficacy of Interferon and Pegylated Interferon (PEG-IFN)""; ""22. Efficacy of Lamivudine""; ""23. Comparison Between Lamivudine, Interferon and the Combination of Interferon and Lamivudine""; ""24. Safety of Lamivudine""; ""25. Efficacy of Adefovir""; ""26. Safety of Adefovir""; ""27. First-line Treatment of Chronic Hepatitis B: Adefovir, Lamivudine or Interferon?""
Text of Note
""28. New Drugs in Development""""29. Who Needs to be Treated and How to Explain the Goals to the Patient""; ""30. Management of Relapsers and Nonresponders""; ""31. Management of Patients Coinfected by HBV and HIV""; ""32. Management of Transplanted Patients Chronically Infected by HBV""; ""33. Cost-effectiveness of Treatment""; ""References""; ""III Biochemical Markers: An Alternative to Liver Biopsies""; ""34. Needle Biopsy of the Liver: Value and Limitations""; ""35. Advantage and Limits of Biochemical Markers""; ""References""
Text of Note
""9. Management of Patients with Renal Disease""""10. Other Difficult-to-treat Populations""; ""11. Safety of Interferon, Pegylated Interferon (PEG-IFN) and Ribavirin""; ""12. Who Needs to be Treated and How to Explain the Goals to the Patient""; ""13. What is the Cost-effectiveness of Combination Regiments?""; ""14. Management of Acute Hepatitis C""; ""15. Practical Guidelines for the Management of Hepatitis C""; ""16. New Drugs in Development""; ""References""; ""II Hepatitis B""; ""17. Natural History of Hepatitis B: Epidemiology""
0
8
8
8
SUMMARY OR ABSTRACT
Text of Note
Provides a practical explanation of the natural history and management of the diseases, and examines the benefits of the most recent drugs, and their effects, whether used in isolation or as part of a combination therapy. This second edition expands the coverage of biochemical markers and of the tgreatment of various difficult-to-treat patients.
ACQUISITION INFORMATION NOTE
Source for Acquisition/Subscription Address
Informa Healthcare
Stock Number
9780203357187
OTHER EDITION IN ANOTHER MEDIUM
Title
Hepatitis C and B.
International Standard Book Number
1841843695
TOPICAL NAME USED AS SUBJECT
Biochemical markers-- Therapeutic use.
Hepatitis B-- Treatment.
Hepatitis C-- Treatment.
Interferon-- Therapeutic use.
Hepatitis B, Chronic-- complications.
Hepatitis B, Chronic-- drug therapy.
Hepatitis C, Chronic-- complications.
Hepatitis C, Chronic-- drug therapy.
Hépatite B-- Traitement.
Hépatite C-- Traitement.
Hépatite virale.
FOREIGN LANGUAGE STUDY-- Spanish.
Hepatitis C-- Treatment.
Interferon-- Therapeutic use.
(SUBJECT CATEGORY (Provisional
FOR-- 026000
DEWEY DECIMAL CLASSIFICATION
Number
616
.
3623061
Edition
22
LIBRARY OF CONGRESS CLASSIFICATION
Class number
RC848
.
H42
Book number
.
P69
2004eb
OTHER CLASS NUMBERS
Class number
2004
J-822
Class number
WC
536
Book Number
P892h
2004
PERSONAL NAME - PRIMARY RESPONSIBILITY
Poynard, T., (Thierry)
PERSONAL NAME - ALTERNATIVE RESPONSIBILITY
Poynard, T., (Thierry).
ORIGINATING SOURCE
Date of Transaction
20201206235828.0
Cataloguing Rules (Descriptive Conventions))
pn
ELECTRONIC LOCATION AND ACCESS
Electronic name
مطالعه متن کتاب [Book]
Y
